Changing Patterns in Retail Drug Distribution PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Changing Patterns in Retail Drug Distribution PDF full book. Access full book title Changing Patterns in Retail Drug Distribution by . Download full books in PDF and EPUB format.
Author:
Publisher:
ISBN:
Category : Drugstores
Languages : en
Pages : 96
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Drugstores
Languages : en
Pages : 96
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Marketing
Languages : en
Pages : 746
Get Book Here
Book Description
Author: Edward Benjamin Weiss
Publisher:
ISBN:
Category : Chain stores
Languages : en
Pages : 76
Get Book Here
Book Description
Author: John Williams Wingate
Publisher:
ISBN:
Category : Retail trade
Languages : en
Pages : 412
Get Book Here
Book Description
Author: Aaron Hamilton Chute
Publisher:
ISBN:
Category : Retail trade
Languages : en
Pages : 20
Get Book Here
Book Description
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377
Get Book Here
Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Author:
Publisher:
ISBN:
Category : Marketing
Languages : en
Pages : 550
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Marketing
Languages : en
Pages : 712
Get Book Here
Book Description
Author: United States. Congress. House
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 2072
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
